Ovarian reserve — the quantity and quality of eggs remaining in the ovaries — is one of the most discussed topics in fertility medicine for women over 35. Yet it’s also one of the most commonly misunderstood. Many women encounter terms like “low ovarian reserve” or “diminished ovarian reserve” in clinical settings or online, often without a clear explanation of what these tests actually measure, what their results mean in practical terms, and what they don’t tell you.
This article aims to demystify ovarian reserve testing: what it involves, how results are interpreted, and how to have an informed conversation with your healthcare provider about what your individual picture means. It is not a substitute for medical evaluation — ovarian reserve is highly individual and the significance of any particular result depends on context that only a specialist can assess.
What Is Ovarian Reserve?
Women are born with a finite number of eggs, and this pool diminishes continuously throughout life. Unlike sperm, which are continuously produced, eggs cannot be regenerated. By the time a woman reaches her mid-30s, she retains a smaller proportion of her original egg supply — and the rate of decline tends to accelerate after this point.
Ovarian reserve refers to this remaining egg pool — though “reserve” is a slightly misleading term, since it implies a stockpile that could be drawn on strategically. In reality, the number and quality of eggs available in any given cycle is influenced by multiple factors beyond total egg count, including the hormonal environment, chromosomal integrity of individual eggs, and other biological variables that testing cannot fully capture.
According to the American College of Obstetricians and Gynecologists, age is the most significant factor in egg quality decline, and this is not directly measurable by current ovarian reserve tests. This distinction is important: tests that measure ovarian reserve are estimating quantity, not quality.
Common Ovarian Reserve Tests
Anti-Müllerian Hormone (AMH)
AMH is a hormone produced by the granulosa cells of small developing follicles in the ovaries. Because it reflects the number of follicles actively developing, it serves as a proxy measure of the remaining egg pool. AMH is one of the most widely used ovarian reserve markers because it can be measured at any point in the menstrual cycle and remains relatively stable from cycle to cycle.
Lower AMH values are associated with reduced ovarian reserve, while higher values suggest a larger pool. However, AMH alone does not predict whether conception will occur in a given cycle, nor does it accurately predict an individual’s fertility potential. Research has shown that AMH levels do not reliably predict natural conception rates — a woman with low AMH may still conceive naturally, while someone with normal AMH may still face other fertility challenges.
Antral Follicle Count (AFC)
AFC involves using transvaginal ultrasound, typically early in the menstrual cycle, to count the number of small (“antral”) follicles visible in both ovaries. These follicles contain immature eggs and provide an estimate of how many eggs might be available in a given cycle. Like AMH, AFC is a measure of quantity rather than quality.
AFC results can vary between cycles and between the clinicians performing the scan. This variability means that a single AFC measurement should be interpreted with appropriate caution, and ideally in conjunction with other clinical information.
Day 3 FSH and Estradiol
Follicle-stimulating hormone (FSH) measured on day 3 of the menstrual cycle is one of the older ovarian reserve markers. Elevated FSH suggests that the pituitary gland is working harder to stimulate the ovaries — a pattern associated with diminished ovarian reserve. Estradiol is often measured at the same time, as elevated early-cycle estradiol can suppress FSH and lead to a falsely reassuring result.
FSH is more cycle-variable than AMH and has largely been supplemented by AMH and AFC in many fertility clinics, though it remains in use, particularly as a screening test in primary care settings.
What Ovarian Reserve Test Results Mean — and Don’t Mean
Understanding the limitations of these tests is as important as understanding what they measure. Several key points are worth keeping in mind:
They measure quantity, not quality. The most clinically significant aspect of age-related fertility decline — egg quality and chromosomal integrity — is not captured by AMH, AFC, or FSH. A woman with normal AMH may still have age-related egg quality issues; a woman with low AMH may still produce viable eggs.
They don’t predict natural pregnancy rates. Studies have found that among women trying to conceive naturally, AMH levels do not accurately predict who will conceive in a given timeframe. These tests are more informative in the context of assisted reproduction, where they help clinicians predict ovarian response to stimulation medications.
Reference ranges vary. “Normal” AMH values differ between laboratories and between age groups. A value that appears low for a 25-year-old may be typical for a 38-year-old. Results should always be interpreted in the context of age and the reference ranges used by the specific laboratory that performed the test.
For broader context on what fertility evaluations after 35 typically involve, our article on understanding fertility evaluations after 35 provides a useful overview of the testing landscape.
How Ovarian Reserve Fits Into Fertility Assessment
Ovarian reserve testing is typically one component of a broader fertility evaluation rather than a standalone assessment. A complete fertility workup for a woman after 35 usually also considers uterine and tubal anatomy, ovulatory function, hormonal profiles, and — in couples — sperm parameters.
When ovarian reserve tests indicate reduced reserve, a reproductive endocrinologist can discuss what this means for different family-building options, including natural conception, intrauterine insemination (IUI), in vitro fertilisation (IVF), or other pathways. The significance of any result is highly individual, and a specialist is the most appropriate person to help interpret results in context.
If you’re in the process of evaluating your fertility options, understanding what the fertility landscape looks like for women over 35 more broadly may help provide useful context alongside specific test results.
Frequently Asked Questions
Can I improve my ovarian reserve?
Current scientific consensus does not support the idea that ovarian reserve — the total pool of remaining eggs — can be meaningfully increased. What may be modifiable are lifestyle factors that could affect egg quality and reproductive health more broadly, such as smoking cessation, maintaining a healthy weight, and managing chronic health conditions. A healthcare provider can offer guidance relevant to your individual situation.
Should I get my ovarian reserve tested if I’m not ready to try to conceive yet?
This is a nuanced decision that depends on your circumstances and what you’d do with the information. For some women, knowing their ovarian reserve helps inform family planning timelines. For others, a low result without current plans to act on it can cause unnecessary anxiety without changing their decisions. Discussing the potential benefits and limitations of testing with your gynaecologist is a good starting point.
What does a low AMH result mean for my chances of conceiving naturally?
Research indicates that AMH does not reliably predict natural conception rates. Some studies have found that women with low AMH have similar natural conception rates over time compared to those with normal AMH, when age is taken into account. A low AMH result is more clinically significant in the context of assisted reproduction (where it predicts how the ovaries will respond to stimulation) than as a predictor of whether natural conception is possible.
At what point should I see a fertility specialist?
ACOG recommends that women over 35 who have been trying to conceive for 6 months without success consult a reproductive specialist. Women over 40, or those with known risk factors for reduced fertility (such as irregular cycles, previous pelvic surgery, or known endometriosis), may benefit from earlier evaluation. Your primary care provider or gynaecologist can provide initial guidance on appropriate timing.
Key Takeaways
- Ovarian reserve tests (AMH, AFC, Day 3 FSH) measure egg quantity, not egg quality — the distinction matters significantly for interpreting results
- AMH is widely used because it’s cycle-stable and provides a reasonable proxy for remaining egg pool size, but it doesn’t predict natural conception rates
- Results should always be interpreted in the context of age, laboratory reference ranges, and a complete clinical picture — not in isolation
- A reproductive endocrinologist is the most appropriate specialist to help interpret ovarian reserve results and discuss implications for fertility options
- ACOG recommends that women over 35 who haven’t conceived after 6 months of trying consult a fertility specialist
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your fertility or reproductive health.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.